Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer (NYSE: PFE) announced that the companies have agreed to stop the Phase 3 AVERROES clinical trial of apixaban in patients with atrial fibrillation.
Original Source of AVERROES Study Closes Early Due to Clear Evidence of Efficacy
A collection of advocacy groups have come together to challenge a series of conferences being offered in India on pharma intellectual property issues. The conferences, which are backed by drugmakers, law firms and the George Washington University Law School, are part of an effort known as the India Project….
GlaxoSmithKline’s ( NYSE: GSK ) diabetes drug Avandia has received a lot of bad press recently. The latest: The FDA may be delaying publication of a new Avandia study underscoring significant risks targeted by previous independent research, Pharmalot reports.
Cardinal Health will acquire specialty pharmaceuticals firm Healthcare Solutions Holding for $517 million in a deal that highlights the growing importance of the specialty drug sector.
Well, the rumors you’ve been hearing have been confirmed:
Pfizer ( NYSE: PFE ) is in trouble today with the announcement that the
Federal Trade Commission Chairman Jon Leibowitz is on the hot seat this week. He faced intense scrutiny
Daiichi Sankyo Company Limited (“Daiichi Sankyo”) and Ranbaxy Laboratories Limited (“Ranbaxy”) announced today that Ranbaxy has launched a generic version of prasugrel in India. The product, called Prasita, is an antiplatelet agent for the prevention of atherothrombotic events in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Original Source…
Nearly nine in 10 people think feeling weaker is one of the worst parts about aging, according to a recent survey commissioned by Abbott and developed in conjunction with the AGS Foundation for Health in Aging, a nonprofit dedicated to the health and well-being of older adults, which provided expert,…
Debt-laden Greece will exceed its target of slashing healthcare spending by €1.2 billion ($1.4 billion)